Literature DB >> 18696213

Aortic valve replacement in a patient with liver cirrhosis and coagulopathy.

Mohammad Hassan Nemati1, Behrooz Astaneh, Mahmood Zamirian.   

Abstract

Open heart surgery in patients with end-stage liver disease is accompanied by various complications. Coagulopathy resulting from liver failure tends to cause uncontrollable hemorrhage. Severe aortic insufficiency has moderate to severe risk for liver transplantation. It can lead to heart failure, liver congestion, and finally rejection of the transplanted liver. Aortic valve replacement in patients diagnosed as having cirrhosis has a significant risk of mortality because of the above-mentioned complications. We present a patient with liver cirrhosis and severe aortic insufficiency who had thrombocytopenia and severe coagulopathy. Aortic valve replacement was performed successfully using cardiopulmonary bypass before the liver transplantation. Hemostasis management was done effectively perioperation. The postoperative course was uneventful, and the patient was discharged after 10 days. Liver transplantation was performed successfully 2 months later.

Entities:  

Mesh:

Year:  2008        PMID: 18696213     DOI: 10.1007/s11748-008-0270-7

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  8 in total

1.  Open heart surgery in a patient with liver cirrhosis and thrombocytopenia.

Authors:  H Yaku; G G Fermanis; D A Horton
Journal:  Aust N Z J Surg       Date:  2000-01

2.  Combined cardiac surgery and liver transplantation.

Authors:  D E Eckhoff; L Frenette; M T Sellers; B M McGuire; J L Contreras; J S Bynon; D C McGiffin
Journal:  Liver Transpl       Date:  2001-01       Impact factor: 5.799

3.  The safety of cardiac operations in the liver transplant recipient.

Authors:  G Prabhakar; G Testa; O Abbasoglu; D R Jeyarajah; R M Goldstein; M F Levy; B S Husberg; T A Gonwa; G B Klintmalm
Journal:  Ann Thorac Surg       Date:  1998-04       Impact factor: 4.330

4.  Case 3-1995. Three patients requiring both coronary artery bypass surgery and orthotopic liver transplantation.

Authors:  J J Morris; C L Hellman; B J Gawey; M A Ramsay; T R Valek; T C Gunning; T H Swygert; L Shore-Lesserson; F Lalehzarian; K L Brayman
Journal:  J Cardiothorac Vasc Anesth       Date:  1995-06       Impact factor: 2.628

5.  Cardiac operations in solid-organ transplant recipients.

Authors:  S N Mitruka; B P Griffith; R L Kormos; B G Hattler; F A Pigula; R Shapiro; J J Fung; S M Pham
Journal:  Ann Thorac Surg       Date:  1997-11       Impact factor: 4.330

6.  Short- and long-term results of open heart surgery in patients with abdominal solid organ transplant.

Authors:  Minoru Ono; Randall K Wolf; Dimitrios C Angouras; David A Brown; Andrew H Goldstein; Robert E Michler
Journal:  Eur J Cardiothorac Surg       Date:  2002-06       Impact factor: 4.191

Review 7.  [Aortic valve replacement for a patient associated with severe liver cirrhosis].

Authors:  A Mizuhara; T Ino; H Adachi; H Ide; A Yamaguchi; K Kawahito
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1994-08

8.  Early and late outcome of cardiac surgery in patients with liver cirrhosis.

Authors:  Farzan Filsoufi; Sacha P Salzberg; Parwis B Rahmanian; Thomas D Schiano; Hussien Elsiesy; Anthony Squire; David H Adams
Journal:  Liver Transpl       Date:  2007-07       Impact factor: 5.799

  8 in total
  2 in total

1.  Haemostatic management for aortic valve replacement in a patient with advanced liver disease.

Authors:  Laurence Weinberg; Irene Kearsey; Clarissa Tjoakarfa; George Matalanis; Sean Galvin; Scott Carson; Rinaldo Bellomo; Larry McNicol; Peter McCall
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

Review 2.  Optimal management of familial hypercholesterolemia: treatment and management strategies.

Authors:  Mohammad Hassan Nemati; Behrooz Astaneh
Journal:  Vasc Health Risk Manag       Date:  2010-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.